Story
Argenx Downgraded to Hold by Berenberg on Valuation After Sharp Rally

Berenberg downgraded shares of biotech firm argenx to "hold" from "buy" on Tuesday, citing valuation concerns after a significant run-up in the stock price. The move comes despite the investment bank raising its price target on the company, signaling a positive view of its underlying business prospects but limited near-term upside for the shares.
Valuation Triggers Downgrade
The primary driver for the rating change is the stock's recent performance. According to Berenberg, argenx shares have rallied almost 50% since the firm initiated its "buy" rating in March.
Berenberg's analysts noted that this sharp increase has made the company's valuation less compelling. The downgrade reflects a view that much of the positive outlook is now priced into the stock, leaving less room for future gains for investors at current levels.
Vyvgart Outlook Strengthens
AdParadoxically, the downgrade was accompanied by an increase in Berenberg's price target for argenx, which was lifted to €925 from a previous €900. This optimism is tied to the company's flagship drug, Vyvgart.
The higher price target follows positive preliminary results from Vyvgart's Phase 3 ALKIVIA study in myositis, an inflammatory muscle disease. Based on this data, Berenberg has increased its peak sales forecast for Vyvgart to $14 billion. The firm stated that the trial results largely supported its prior analysis and strengthen the case for the drug's market expansion.
Market Impact
Despite the downgrade, argenx shares showed resilience in Tuesday's trading, rising 1.2% to €874.60. This followed a 4.2% decline in the previous session. The market's reaction suggests investors may be weighing the positive long-term drug pipeline developments against the more cautious near-term valuation assessment from the bank.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.